Premphase and breast cancer recurrent Patient Reports February 10, 2012

Premphase Side Effects Report #4947733-6
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Female patient, 50 years of age, weighting 180.2 lb, was diagnosed with menopause  and was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast cancer metastatic, breast cancer recurrent. Premphase dosage: unknown. Patient was hospitalized. Patient recovered.

Premphase Side Effects Report #5041482-4
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 59 years of age, weighting 162.1 lb, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast cancer metastatic, breast cancer recurrent, lung adenocarcinoma, metastases to lung, metastases to lymph nodes, non-small cell lung cancer, oestrogen receptor assay positive, pneumothorax. Premphase dosage: unknown. During the same period patient was treated with CYCRIN, PREFEST, PREMARIN, PROVERA. Patient was hospitalized. Patient recovered.

Premphase Side Effects Report #5385603-2
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, weighting 180.2 lb, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer recurrent. Premphase dosage: unknown. Patient recovered.

Premphase Side Effects Report #5502612-0
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2007. Female patient, weighting 180.2 lb, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer recurrent. Premphase dosage: unknown. Patient recovered.